SHR9549
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 01, 2022
SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer
(clinicaltrials.gov)
- P1 | N=4 | Terminated | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | N=44 ➔ 4 | Unknown status ➔ Terminated; Sponsor R & D Strategy Adjustment
Enrollment change • Trial termination • Breast Cancer • HER2 Breast Cancer • HER2 Negative Breast Cancer • Hormone Receptor Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • ER • HER-2
1 to 1
Of
1
Go to page
1